더바이오 11월 9일 주요뉴스

[https://www.thebionews.net/edit/webzine.html?idxno=679](https://www.thebionews.net/edit/webzine.html?idxno=679)

● 불붙은 ‘TL1A’ 이중항체 개발 경쟁…美 칼데라 임상 진전·中 기술수출 확대
[https://www.thebionews.net/news/articleView.html?idxno=29979](https://www.thebionews.net/news/articleView.html?idxno=29979)

● 동아에스티, 영업익 회복·뇌전증 신약 가세…별도기준 연매출 8000억 청신호
[https://www.thebionews.net/news/articleView.html?idxno=29975](https://www.thebionews.net/news/articleView.html?idxno=29975)

● 셀트리온제약, 고수익 ‘시밀러’ 타고 성장 가속…2028년 영업익 1000억 전망
[https://www.thebionews.net/news/articleView.html?idxno=29974](https://www.thebionews.net/news/articleView.html?idxno=29974)

● 새비로보틱스 “로봇으로 바이오 공정 ‘자동화’…비용·오염까지 잡는다”
[https://www.thebionews.net/news/articleView.html?idxno=29978](https://www.thebionews.net/news/articleView.html?idxno=29978)

● 차상훈 에이프릴 대표 “기업가치 변함없어…‘4300억 실탄’ 바탕 R&D 가속”
[https://www.thebionews.net/news/articleView.html?idxno=30018](https://www.thebionews.net/news/articleView.html?idxno=30018)

● 대웅제약, 고농도 SC서 붙이는 패치까지…차세대 약물 전달 기술 개발 본격화
[https://www.thebionews.net/news/articleView.html?idxno=30010](https://www.thebionews.net/news/articleView.html?idxno=30010)

● 스위스 크리스퍼, 동종 유래 CAR-T ‘주고-셀’ 전신경화증 1상서 반응률 83%
[https://www.thebionews.net/news/articleView.html?idxno=30015](https://www.thebionews.net/news/articleView.html?idxno=30015)

● 美 카발레타, CAR-T 후보 자가면역질환 1·2상서 면역조절제 없이 1년 효과
[https://www.thebionews.net/news/articleView.html?idxno=30022](https://www.thebionews.net/news/articleView.html?idxno=30022)

● J&J, IL-23 경구제 ‘이코타이드’ 건선성 관절염 3상 관절·피부 병변 동시 개선
[https://www.thebionews.net/news/articleView.html?idxno=30020](https://www.thebionews.net/news/articleView.html?idxno=30020)

● 노보노디스크, ‘위고비’ BMI 27 미만 MASH 환자서 간 손상·섬유화 지표 개선
[https://www.thebionews.net/news/articleView.html?idxno=30012](https://www.thebionews.net/news/articleView.html?idxno=30012)

● 셀트리온제약, 3Q 역대 최대 분기 실적…누적 영업익 작년 연간 실적 웃돌아
[https://www.thebionews.net/news/articleView.html?idxno=30025](https://www.thebionews.net/news/articleView.html?idxno=30025)

● 엠비디, 상장 발판 ‘3D 세포배양’ 글로벌 공략…장비·진단·CRO 키운다
[https://www.thebionews.net/news/articleView.html?idxno=30013](https://www.thebionews.net/news/articleView.html?idxno=30013)

● 에이프릴바이오, ‘R&D Day 2026’ 개최…“파이프라인 확장 전략 공개”
[https://www.thebionews.net/news/articleView.html?idxno=30026](https://www.thebionews.net/news/articleView.html?idxno=30026)

● 엘앤씨바이오, 3Q 누적 매출 첫 1000억원 돌파…영업익 전년比 892%↑
[https://www.thebionews.net/news/articleView.html?idxno=30019](https://www.thebionews.net/news/articleView.html?idxno=30019)

● 인천, ‘바이오 스타트업 파트너링 데이’ 개최…투자 유치·오픈 이노베이션 지원
[https://www.thebionews.net/news/articleView.html?idxno=30000](https://www.thebionews.net/news/articleView.html?idxno=30000)

● 앱클론, 종근당과 차세대 CAR-T ‘네스페셀’ 국내 독점 판매한다
[https://www.thebionews.net/news/articleView.html?idxno=30017](https://www.thebionews.net/news/articleView.html?idxno=30017)

● 셀트리온, 유럽서 ‘스테키마’ 소아 크론병·궤양성대장염 적응증 추가승인 권고
[https://www.thebionews.net/news/articleView.html?idxno=30001](https://www.thebionews.net/news/articleView.html?idxno=30001)

● 삼성바이오에피스, SITC 2026서 키트루다 시밀러 ‘SB27’ 3상 동등성 확인
[https://www.thebionews.net/news/articleView.html?idxno=29985](https://www.thebionews.net/news/articleView.html?idxno=29985)

● SK바이오팜, 美서 개소한 K-바이오 혁신 상생 플랫폼 ‘링스’ 입주사 31곳 선정
[https://www.thebionews.net/news/articleView.html?idxno=30014](https://www.thebionews.net/news/articleView.html?idxno=30014)

● 디앤디, AASLD서 ‘자보페그두타이드’ 48주 최종 조직생검 결과 ‘구두’ 발표
[https://www.thebionews.net/news/articleView.html?idxno=30011](https://www.thebionews.net/news/articleView.html?idxno=30011)

● ﻿﻿﻿﻿﻿﻿﻿﻿Samsung Bioepis confirms Phase 3 equivalence of Keytruda biosimilar ‘SB27’ at SITC 2026
[https://www.thebionews.net/news/articleView.html?idxno=30033](https://www.thebionews.net/news/articleView.html?idxno=30033)

●﻿﻿ LigaChem Biosciences takes part in ‘BIO-Europe’ and ‘Jefferies Global Healthcare Conference’ back to back
[https://www.thebionews.net/news/articleView.html?idxno=30032](https://www.thebionews.net/news/articleView.html?idxno=30032)

● Seegene posts KRW 11.6 billion Q3 operating profit, up 21.2%, as non-respiratory product sales rise 12.3% year-on-year
[https://www.thebionews.net/news/articleView.html?idxno=30030](https://www.thebionews.net/news/articleView.html?idxno=30030)

● ﻿﻿﻿LAMEDITECH wins MFDS approval for ‘LAINJET,’ a laser medical device specialized for skin boosters
[https://www.thebionews.net/news/articleView.html?idxno=30031](https://www.thebionews.net/news/articleView.html?idxno=30031)

● ﻿﻿﻿﻿Alteogen expands partnerships at BIO Europe, showcasing new macular degeneration drug and Hybrozyme
[https://www.thebionews.net/news/articleView.html?idxno=30029](https://www.thebionews.net/news/articleView.html?idxno=30029)

● Sky Labs targets local market through clinics under PureHealth, Middle East's largest healthcare group
[https://www.thebionews.net/news/articleView.html?idxno=30028](https://www.thebionews.net/news/articleView.html?idxno=30028)

● ﻿Savvy Robotics: “Robots automate bioprocesses, keeping costs and contamination in check”
[https://www.thebionews.net/news/articleView.html?idxno=30027](https://www.thebionews.net/news/articleView.html?idxno=30027)

*제약바이오 11월 9일 아침 유튜브 라디오 뉴스(매일 아침 업로드)
[https://www.youtube.com/watch?v=8mQty2fNJnU](https://www.youtube.com/watch?v=8mQty2fNJnU)